USA: FDA Slaps Bladder Cancer Warning on Actos

Posted on June 16, 2011


USA: The FDA announced today warned consumers that the drug Actos, popular for the treatment of diabetes, increases the risk for bladder cancer if used more than one year. Germany and France pulled Actos for the same reason several days ago. Avandia has already been removed from the market due to heart risks; it is in the same class as Avandia.  Steven Reinberg with  HealthDay News offers this complete coverage.